1. Yokoyama, Takashi, Nakatake, Mayuka, Kuwata, Takeshi, Delwel, Ruud, Nakamura, Takuro. 2016. MEIS1-mediated transactivation of synaptotagmin-like 1 promotes CXCL12/CXCR4 signaling and leukemogenesis. In The Journal of clinical investigation, 126, 1664-78. doi:10.1172/JCI81516. https://pubmed.ncbi.nlm.nih.gov/27018596/
2. Wang, Jiansong, Luo, Jianjun, Wu, Xuecheng, Li, Zhuo. 2022. ELK1 suppresses SYTL1 expression by recruiting HDAC2 in bladder cancer progression. In Human cell, 35, 1961-1975. doi:10.1007/s13577-022-00789-z. https://pubmed.ncbi.nlm.nih.gov/36107384/
3. Meijuan, Cai, Meng, Xu, Fang, Liu, Qian, Wang. 2023. Synaptotagmin-like protein 1 is a potential diagnostic and prognostic biomarker in endometrial cancer based on bioinformatics and experiments. In Journal of ovarian research, 16, 16. doi:10.1186/s13048-023-01097-2. https://pubmed.ncbi.nlm.nih.gov/36653850/
4. Wang, Jiansong, Luo, Jianjun, Wu, Xuecheng, Li, Zhuo. 2023. WTAP enhances the instability of SYTL1 mRNA caused by YTHDF2 in bladder cancer. In Histology and histopathology, 39, 633-646. doi:10.14670/HH-18-671. https://pubmed.ncbi.nlm.nih.gov/37933909/
5. Lian, Lian, Teng, Shi-Bing, Xia, You-You, Xu, Xue-Fei, Zhou, Chong. . Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma. In Journal of gastrointestinal oncology, 13, 462-477. doi:10.21037/jgo-22-69. https://pubmed.ncbi.nlm.nih.gov/35557566/
智鼠故事 
